Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Visningar
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Visa mer
Facebook-kommentarer
Inga kommentarer hittades